PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.) lobbying for PMI US CORPORATE SERVICES INC. (FKA PMI GLOBAL SERVICES INC.)

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$1,320,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

KICHELLE WEBSTER TOMLINSON New on this filing

Previously held: None

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

Food & Drug Administration (FDA)
HOUSE OF REPRESENTATIVES
SENATE
Treasury, Dept of
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025

Lobbying activity 6

Budget/Appropriations

H.R. ___/S.___, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2025; discussions related to tobacco harm reduction.

Foreign Relations

Discussions related to U.S. policy guidance provided to executive branch personnel regarding foreign government engagements.

Taxation/Internal Revenue Code

H.R. 1968: Full-Year Continuing Appropriations and Extensions Act, 2025; discussions related to federal excise drawback laws. Discussions related to federal excise tax drawback laws and their application to manufacturing of tobacco products.

Tobacco

Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to the importance of tobacco harm reduction and the availability of FDA-authorized smoke-free products. Discussions related to enforcement of illicit tobacco products, including importation and distribution of counterfeit products. Discussions related to user fees for tobacco products. Discussions related to efforts to prevent underage access to tobacco products. Discussions related to reforms of the Food and Drug Administrations Center for Tobacco Products. Discussions related to PMTA and MRTPA submissions and FDA authorization of scientifically-substantiated products.

Trade (domestic/foreign)

Discussions related to potential tariffs on imported products.

Veterans

Discussions related to Veterans and health related issues.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

PHILIP MORRIS PRODUCTS S.A. (PARENT COMPANY IS PMI)

Switzerland · Neuchatel · owns 0% of the client · contributed $10,000.00